Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Marinus Pharmaceuticals Inc (MRNS)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Marinus Pharma's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
1.480 +0.070    +4.96%
11:44:12 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,123,415
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.390 - 1.550
Marinus Pharma 1.480 +0.070 +4.96%

NASDAQ:MRNS Financials

 
A brief overview of the NASDAQ:MRNS financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Marinus Pharmaceuticals Inc over time.

Marinus Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 30.99 million compared to USD 25.48 million a year ago. Net loss was USD 141.41 million compared to USD 19.82 million a year ago. Basic loss per share from continuing operations was USD 2.63 compared to USD 0.51 a year ago. Diluted loss per share from continuing operations was USD 2.63 compared to USD 0.51 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MRNS Income Statement

Gross margin TTM -226.96%
Operating margin TTM -424.3%
Net Profit margin TTM -456.31%
Return on Investment TTM -65.17%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 7.19 7.34 6.08 10.38
Gross Profit -20.08 -16.78 4.23 -17.76
Operating Income -35.44 -31.65 -31.44 -32.96
Net Income -41.77 -32.97 -31.93 -34.73

MRNS Balance Sheet

Quick Ratio MRQ 3.79
Current Ratio MRQ 4.07
LT Debt to Equity MRQ 567.78%
Total Debt to Equity MRQ 658.26%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 170.91 200.81 201.2 226.82
Total Liabilities 154.14 146.27 143.86 141.73
Total Equity 16.76 54.54 57.34 85.08

MRNS Cash Flow Statement

Cash Flow/Share TTM -2.16
Revenue/Share TTM 0.57
Operating Cash Flow  -66.45%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -26.99 -25.17 -24.36 -41.48
Cash From Investing Activities 6.47 11.92 5 -52
Cash From Financing Activities 0.661 25.9 0.237 -0.174
Net Change in Cash -19.86 12.65 -19.12 -93.65
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

MRNS Comments

Write your thoughts about Marinus Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Ryan Watkins
Ryan Watkins Apr 15, 2024 11:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
anything else in the pipeline or will the future be a real struggle ?
Reply
0 0
Report
Shadi Jordan
Shadi Jordan Mar 15, 2021 8:55AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Now invest in gold
Reply
0 0
Report
Florin Tudor
Florin Tudor Oct 09, 2020 6:52AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hold! it will fly to 30$$$
Reply
1 1
Report
sum Cheng
sum Cheng Sep 15, 2020 11:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought at 3.50 what should i do?
Reply
0 0
Report
Pewbaca PewPew
Pewbaca PewPew Sep 15, 2020 11:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
My suggestion: Sell and learn from it. "One trick" Pharma and Biotech companys are way to risky to keep them as an investment.
Reply
1 2
Report
Leandro Planell
Leandro Planell Sep 15, 2020 11:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hope you didn't sell😷
Reply
0 0
Report
Leandro Planell
Leandro Planell Sep 15, 2020 11:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hope you didn't sell😷
Reply
0 0
Report
Leandro Planell
Leandro Planell Sep 15, 2020 11:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hope you didn't sell😷
Reply
0 0
Report
sum Cheng
sum Cheng Sep 15, 2020 11:22PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
bought at 3.50 what should I do?
Reply
0 0
Report
hakim messaoudi
hakim messaoudi Sep 15, 2020 12:58PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
going back to $2
Reply
1 4
Report
Florin Tudor
Florin Tudor Sep 15, 2020 12:58PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lol:)))
Reply
0 0
Report
Nicolas Daoud
Nicolas Daoud Sep 15, 2020 12:54PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Ready to go to the moon
Reply
1 0
Report
Zarathoustra zarathoustra
Zarathoustra zarathoustra Sep 15, 2020 11:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
we need to break that 3.90 ceiling
Reply
2 0
Report
Mithushan saravanabavan
Mithushan saravanabavan Sep 15, 2020 10:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It'll go to 4.50+ according to my analysis on the graph
Reply
2 0
Report
Zarathoustra zarathoustra
Zarathoustra zarathoustra Sep 15, 2020 10:18AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
yes.. and with the phase 3 results, its just a few weeks/months before it gets on the market and gain big revenues or days before it gets BO
Reply
0 0
Report
Anna Phillips
Anna Phillips May 20, 2020 10:20AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
# MeTo
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email